Mosanna Therapeutics is a pre-clinical biotech company developing a medicinal nasal spray for obstructive sleep apnea. The company aims to expand the range of treatment options for OSA and provide therapy in a familiar, user-friendly modality.
Ben Machielse | Chairman
Jonathan Talbot, PhD | Founder & CEO
Have an idea? Building a company? Seeking to partner with our portfolio companies? Please reach out, we’d love to hear from you.Get In Touch